1. Home
  2. OII vs SYRE Comparison

OII vs SYRE Comparison

Compare OII & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oceaneering International Inc.

OII

Oceaneering International Inc.

HOLD

Current Price

$23.30

Market Cap

2.3B

Sector

Energy

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$33.64

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OII
SYRE
Founded
1964
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.6B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
OII
SYRE
Price
$23.30
$33.64
Analyst Decision
Hold
Strong Buy
Analyst Count
4
6
Target Price
$25.00
$56.50
AVG Volume (30 Days)
742.2K
744.8K
Earning Date
10-22-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
73.60
N/A
EPS
2.29
N/A
Revenue
$2,829,032,000.00
N/A
Revenue This Year
$5.93
N/A
Revenue Next Year
$0.78
N/A
P/E Ratio
$10.50
N/A
Revenue Growth
8.71
N/A
52 Week Low
$15.46
$10.91
52 Week High
$28.31
$35.31

Technical Indicators

Market Signals
Indicator
OII
SYRE
Relative Strength Index (RSI) 36.81 67.93
Support Level $26.76 $32.26
Resistance Level $27.64 $34.32
Average True Range (ATR) 0.91 1.80
MACD -0.37 -0.18
Stochastic Oscillator 0.67 75.52

Price Performance

Historical Comparison
OII
SYRE

About OII Oceaneering International Inc.

Oceaneering International Inc is a provider of engineered services and products and robotic solutions to the offshore energy, defense, aerospace, manufacturing, and entertainment industries. A majority of its products are produced for the offshore oil and gas market. The company's business segments are Integrity Management and Digital Solutions, Subsea Robotics, Manufactured Products, Offshore Projects Group, and Aerospace and Defense Technologies. Maximum revenue is generated from its Subsea Robotics segment, which provides remotely operated vehicles (ROVs) for drill support and vessel-based services, underwater surveys, tooling, and other activities. Geographically, the company derives its key revenue from the United States, followed by Africa, Norway, Brazil, and other regions.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: